A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome

The Journal of Pediatrics

Volumn 123, Issue 5, 1993, Pages 757-766

  Horbar, Jeffery D ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Wright, Linda L ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Soll, Roger F ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Wright, Elizabeth C ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Fanaroff, Avroy A ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Korones, Sheldon B ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Shankaran, Seetha ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Oh, William ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Fletcher, Barry D ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Bauer, Charles R ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Tyson, Jon E ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Lemons, James A ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Donovan, Edward F ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Stoll, Barbara J ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Stevenson, David D ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Papile, Lu Ann ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Philips III, Joseph ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}  

^a UNIVERSITY OF VERMONT   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g Bron University ^*  (United States)

^h ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

ⁱ UNIVERSITY OF MIAMI   (United States)

^j UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^k INDIANA UNIVERSITY   (United States)

^l UNIVERSITY OF CINCINNATI   (United States)

^m EMORY UNIVERSITY   (United States)

ⁿ STANFORD UNIVERSITY   (United States)

^o UNIVERSITY OF NEW MEXICO   (United States)

^p UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME;

COMPARATIVE STUDY; DRUG COMBINATIONS; FATTY ALCOHOLS; FEMALE; HUMAN; INFANT, NEWBORN; MALE; POLYETHYLENE GLYCOLS; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY MECHANICS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TREATMENT OUTCOME;

EID: 0027367647     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(05)80856-X     Document Type: Article

References (41)

1. Respiratory distress syndrome
2. Properties of the urn randomization in clinical trials [published erratum appears in Controlled Clinical Trials 1989;10:following 126]
3. High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants
4. Calculation of mean airway pressure during mechanical ventilation in neonates
5. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period
6. The arterial/alveolar oxygen tension ratio: an index of gas exchange applicable to varying oxygen concentrations
7. Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: effects of dose, dispersion technique and gestationalage
8. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging
9. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birthweights less than 1500 gm
10. An international classification of retinopathy of prematurity
11. Discrete sequential boundaries for clinical trials
12. Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies
13. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant
14. Effects of two rescue doses of Exosurf, Pediatric in 342 750–1249 gram infants [Abstract]
15. Effects of two rescue doses of synthetic surfanctant on mortality rate and survival without bronchopulmonary dysplasia in 700–1350 gram infants with respiratory distress syndrome
16. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome
17. Initial clinical trial of Exosurf, a protein free synthetic surfactant, for the prevention and early treatment of hyaline membrane disease
18. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial
19. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants
20. Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trials
21. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials
22. Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease
23. A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome
24. A multicenter randomized placebo-controlled trial of surfactant therapy for respiratory distress syndrome
25. A European multicenter randomized controlled trial of single-dose surfactant therapy for idiopathic respiratory distress syndrome
26. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birthweight neonates with respiratory distress syndrome
27. Multicenter trial of single-dose modified surfactant extract (Survanta) for prevention of respiratory distress syndrome
28. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome
29. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial
30. Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial
31. Prophylactic treatment of very premature infants with human surfactant
32. Effects of three vs one prophylactic dose of Exosurf Neonatal in 700–1000 gm neonates [Abstract]
33. Early vs delayed neonatal administration of a synthetic surfactant the judgement of OSIRIS
34. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs
35. Effect of surfactant TA on alveolar stability of premature rabbit fetus: comparison with term rabbit fetus and dry surfactant (70% DPPC and 30% PG)
36. Lung function in prematurely delivered rabbits treated with a synthetic surfactant
37. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants